Compagnie Lombard Odier SCmA’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-317
| Closed | -$27K | – | 564 |
|
|
2020
Q2 | $27K | Hold |
317
| – | – | ﹤0.01% | 427 |
|
|
2020
Q1 | $23K | Hold |
317
| – | – | ﹤0.01% | 394 |
|
|
2019
Q4 | $23K | Hold |
317
| – | – | ﹤0.01% | 403 |
|
|
2019
Q3 | $17K | Hold |
317
| – | – | ﹤0.01% | 423 |
|
|
2019
Q2 | $17K | Hold |
317
| – | – | ﹤0.01% | 424 |
|
|
2019
Q1 | $23K | Hold |
317
| – | – | ﹤0.01% | 449 |
|
|
2018
Q4 | $25K | Hold |
317
| – | – | ﹤0.01% | 429 |
|
|
2018
Q3 | $148K | Hold |
317
| – | – | 0.01% | 317 |
|
|
2018
Q2 | $126K | Hold |
317
| – | – | ﹤0.01% | 330 |
|
|
2018
Q1 | $97K | Sell |
317
-316
| -50% | -$96.7K | ﹤0.01% | 372 |
|
|
2017
Q4 | $186K | Buy |
633
+233
| +58% | +$68.5K | ﹤0.01% | 393 |
|
|
2017
Q3 | $219K | Buy |
+400
| New | +$219K | 0.01% | 349 |
|